[1]
Larasati, maria e.a. 2019. Randomized Trial Comparing Adjuvant Intravitreal Triamcinolone Acetonide 2mg and Bevacizumab 12,5mg for Diabetic Macular Edema. Medicinus. 7, 2 (sep. 2019), 35–41. DOI:https://doi.org/10.19166/med.v7i2.1792.